The SEAS Study: Sensory Engagement and Activation During Noninvasive Stimulation
ConditionHealthy Adult Participants
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Minnesota
About this trial
Early feasibility study to establish quantitative physiological markers correlated with noninvasive stimulation.
Eligibility criteria
Qualifiers
Able to provide written informed consent in English.
Willing and able to complete study procedures (e.g., ~1-hour sessions with non-invasive recordings, ~3-hour visit).
Disqualifiers
History of neurological disorders (e.g., epilepsy, migraines) or psychiatric conditions requiring medication.
Active implanted medical devices (e.g., pacemakers, cochlear implants) or metal in the neck/forearm that could interfere with stimulation or recordings.
Skin conditions or open wounds at stimulation sites (cervical neck, forearm).
Women who are pregnant or breastfeeding.
Trial design
Treatments tested in this trial
- External electrical stimulation
- Ultrasound stimulation
Treatment groups
40 Participants
are divided into 2 treatment groupsLocations
3M Health Clinical Research Unit55455, MinneapolisMinnesota, United States
M Health Clinics and Surgery Center and satellite Neurology Clinic locations55455, MinneapolisMinnesota, United States
Translational Neurotechnology (TNT) Lab55455, MinneapolisMinnesota, United States
Sponsors and collaborators
University of Minnesota
Lead sponsor
Source ClinicalTrials.gov